发明名称 |
METHODS FOR IMPROVING THE PHARMACOKINETICS OF HIV INTEGRASE INHIBITORS |
摘要 |
The invention provides methods of increasing the bioavailability of the compound 6-(3-chloro 2-fluorobenzyl)-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4 5 dihydroquinoline-3-carboxylic acid or its pharmaceutically acceptable salt in a patient, comprising: administering to the patient a therapeutically effective amount of the compound or a pharmaceutically acceptable salt thereof, the patient having taken food during the period between from 1 hour prior to the administration of compound to 2 hours after the administration of compound; or administering to a patient a therapeutically effective amount of the compound 10 or a pharmaceutically acceptable salt thereof during the period between from 1 hour prior to the consumption of food to 2 hours after the consumption of food. <filename> |
申请公布号 |
AU2013203476(C1) |
申请公布日期 |
2016.11.17 |
申请号 |
AU20130203476 |
申请日期 |
2013.04.10 |
申请人 |
Japan Tobacco Inc.;Gilead Sciences, Inc. |
发明人 |
Kearney, Brian P.;Kakee, Atsuyuki;Kawaguchi, Isao |
分类号 |
A61K31/426;A61K31/47;A61P31/18 |
主分类号 |
A61K31/426 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|